XML 45 R26.htm IDEA: XBRL DOCUMENT
v3.23.1

Equity - Issued Capital | 12 Months Ended
--- | ---
Dec. 31, 2022
Equity - Issued Capital [Abstract] |
Equity - issued capital | Note 20. Equity - issued capital
|  | Consolidated |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | 2022 |  |  | 2021 |  |  | 2020 |  |  | 2022 |  |  | 2021 |  |  | 2020 |  |  | 2022 |
|  | Shares |  |  | Shares |  |  | Shares |  |  | AUD$ |  |  | AUD$ |  |  | AUD$ |  |  | $ |
Ordinary shares - fully paid |  |  | 1,331,279,665 |  |  |  | 321,936,715 |  |  |  | 257,936,715 |  |  |  | 41,636,762 |  |  |  | 26,504,136 |  |  |  | 22,884,795 |  |  |  | 28,285,844 |
Movements in ordinary share capital
Details |  | Date |  | Shares |  |  | Issue price |  |  | AUD$ |  |  | $ |
Balance |  | 1 January 2020 |  |  | 257,936,715 |  |  |  |  |  |  |  | 22,884,795 |  |  |  |  |
Balance |  | 31 December 2020 |  |  | 257,936,715 |  |  |  |  |  |  |  | 22,884,795 |  |  |  |  |
Placement (*) |  | 17 May 2021 |  |  | 64,000,000 |  |  | $ | 0.06 |  |  |  | 3,840,000 |  |  |  |  |
Capital raising costs |  |  |  |  | - |  |  |  | - |  |  |  | (220,659 | ) |  |  |  |
Balance |  | 31 December 2021 |  |  | 321,936,715 |  |  |  |  |  |  |  | 26,504,136 |  |  |  |  |
Issue of IPO shares (net of warrant fair value)(**) |  | 29 August 2022 |  |  | 885,592,950 |  |  | $ | 0.015 |  |  |  | 13,662,563 |  |  |  | 9,281,632 |
Exercise of 450,000 pre-funded warrants |  | 31 August 2022 |  |  | 123,750,000 |  |  | $ | 0.026 |  |  |  | 4,085,533 |  |  |  | 2,775,498 |
Capital raising costs |  |  |  |  | - |  |  |  | - |  |  |  | (2,615,470 | ) |  |  | (1,776,814 | )
Balance |  | 31 December 2022 |  |  | 1,331,279,665 |  |  |  |  |  |  |  | 41,636,762 |  |  |  | 28,285,844 |
| (*) | On 15 July 2021, the Company issued 64,000,000 options to investors in the Company’s May 2021 capital raising. The options have an exercise price of AUD$0.09 ($0.07), expire July 15, 2023.
| (**) | On 24 August 2022, the Company issued 3,220,338 units to shareholders in the Company’s August 2022 Nasdaq listing & IPO. Each unit consists of a single ADS and single pre-funded warrant exercisable to a single ADS. The warrants have an exercise price of AUD$7.36 ($5.00), expire August 24, 2027.
Ordinary shares Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the Company does not have a limited amount of authorised capital. On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote. Capital risk management The company’s objectives when managing capital is to safeguard its ability to continue as a going concern, so that it can provide returns for shareholders and benefits for other stakeholders and to maintain an optimum capital structure to reduce the cost of capital. Capital is regarded as total equity, as recognised in the statement of financial position, plus net debt. Net debt is calculated as total borrowings less cash and cash equivalents. In order to maintain or adjust the capital structure, the company may adjust the amount of dividends paid to shareholders, return capital to shareholders, issue new shares or sell assets to reduce debt. The company would look to raise capital when an opportunity to invest in a business or company was seen as value adding relative to the current Company’s share price at the time of the investment. The company is not actively pursuing additional investments in the short term as it continues to integrate and grow its existing businesses in order to maximise synergies. Accounting policy for issued capital Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds. Warrants The Company accounts for warrants issued to investors under IFRS 9. a. On August 24, 2022, under Nasdaq dual listing & IPO the Company issued a total of 3,220,338 units each includes single ADS and single tradable pre-funded warrant exercised to single ADS at an exercise price of $5.00. The Company recorded these warrants as a derivative financial liability which represents the fair value of the warrants on the transaction date due to the fact that they do not meet the criteria for a fixed number of equity instruments in exchange for a fixed amount of cash. The derivative financial liability is re-measured at each reporting date, with changes in fair value recognized under fair value gains/(losses) from financial liability. The derivative financial liability as of August 24, 2022, amounted to AUD$5,598,835 ($3,865,996). On December 31, 2022, it amounted to AUD$1,044,955 ($707,957). The amounts were recorded at fair value according to a valuation performed by an independent third-party appraiser. The fair value of the pre-funded warrants was classified as a level 2 fair value measurement. On August 31, 2022, 450,000 pre-funded warrants were exercised into ADS for AUD$3,259,925 ($2,250,000). See also Note 22. The fair value of the pre-funded warrants on August 31, 2022 (exercise date), measured using a Hull-White trinomial option pricing model, was AUD$825,609 ($569,832). b. On August 24, 2022, under Nasdaq dual listing & IPO the Company issued a total 161,017 representative warrants to the underwriter each exercised to single ADS at an exercise price of $5.16. The representative warrant carrying a cashless exercise option with variable exercise mechanism. The Company recorded these warrants as a derivative financial liability which represents the fair value of the warrants on the transaction date due to the fact that they do not meet the criteria for a fixed number of equity instruments in exchange for a fixed amount of cash. The derivative financial liability is re-measured at each reporting date, with changes in fair value recognized under fair value gains/(losses) from financial liability. The derivative financial liability as of August 24,2022 amounted to AUD$281,436 ($194,332), reflecting the average between high and low valuation inputs. On December 31, 2022, it amounted to AUD$52,565 ($39,272) reflecting the average between high and low valuation inputs. The fair value of the representative warrants was classified as a level 2 fair value measurement. The pre-funded warrant and representative warrant are referred herein together as “Warrants”. For the year ended December 31, 2022, the Company recorded fair value gains, net of AUD$3,768,466 ($2,560,099) under the statement of comprehensive loss as a result of the change in the fair value of Warrants. A summary of changes in share purchase warrants issued by the Company during the year ended December 31, 2022 is as follows:
|  | Number of Warrants |  |  | Weighted Average Exercise Price ($) |
Balance, December 31, 2021 |  |  | - |  |  |  |  |
Issuance of warrants |  |  | 3,381,355 |  |  |  | 5.01 |
August 31, 2022 warrants exercise |  |  | (450,000 | ) |  |  | 5.00 |
Balance, December 31, 2022 |  |  | 2,931,355 |  |  |  | 5.01 |
|  | Fair value measurements using input type |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Balance as of December 31, 2021 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Warrants issued during the period |  |  | - |  |  | AUD$ | 5,598,835 |  |  |  | - |  |  | AUD$ | 5,598,835 |
Fair value loss (gain) recognized in consolidated statement of profit or loss and other comprehensive income |  |  | - |  |  |  | (3,768,466 | ) |  |  | - |  |  |  | (3,768,466 | )
Transfer upon exercise |  |  | - |  |  |  | (825,609 | ) |  |  | - |  |  |  | (825,609 | )
Translation adjustments |  |  |  |  |  |  | 92,760 |  |  |  |  |  |  |  | 92,760 |
Warrant liability as of December 31, 2022 |  |  | - |  |  | AUD$ | 1,097,520 |  |  |  | - |  |  | AUD$ | 1,097,520 |

X
- Definition The disclosure of issued capital. [Refer: Issued capital] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfIssuedCapitalExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | mob_DisclosureOfIssuedCapitalTextBlockAbstract
Namespace Prefix: | mob_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration